Blueshift Asset Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-6,449
Closed -$379K 792
2022
Q2
$379K Buy
+6,449
New +$356K 0.06% 387
2021
Q4
Sell
-20,952
Closed -$1.18M 1134
2021
Q3
$1.18M Buy
20,952
+10,014
+92% +$550K 0.07% 366
2021
Q2
$570K Sell
10,938
-2,977
-21% -$143K 0.03% 521
2021
Q1
$613K Buy
+13,915
New +$585K 0.06% 419
2020
Q1
Sell
-5,990
Closed -$243K 544
2019
Q4
$243K Buy
+5,990
New +$223K 0.03% 669

Other funds holding PBH

Blueshift Asset Management's PBH Position: Q3 2022 in Review

Blueshift Asset Management sold out of Prestige Consumer Healthcare (PBH) in Q3 2022, closing a stake of 6,449 shares — an estimated $379K sold.

Blueshift Asset Management first reported a position in PBH in Q4 2019 and held it in 5 quarters. The position peaked at $1.18M in Q3 2021. 279 funds tracked by Wall St. Rank hold PBH as of Q3 2022.

  • Blueshift Asset Management reported no remaining Prestige Consumer Healthcare position as of Q3 2022 after selling out during the quarter.
  • Blueshift Asset Management sold 6,449 Prestige Consumer Healthcare shares in Q3 2022, an estimated $379K.
  • Blueshift Asset Management first reported a position in Prestige Consumer Healthcare in Q4 2019 and held it in 5 quarters.
  • Blueshift Asset Management's Prestige Consumer Healthcare position peaked at $1.18M in Q3 2021.
  • 279 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2022.

Based on Blueshift Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.